Mr. Richard Schnoor reports

VODIS PHARMACEUTICALS INC. CLOSES SECOND TRANCHE OF $492,500 OF NON-BROKERED FINANCING

Vodis Pharmaceuticals Inc. has closed the second tranche of the previously announced non-brokered private placement of up to $1.2-million. The second tranche consists of a total of 4,925,000 shares of the company's stock at the subscription price of 10 cents per common share for gross proceeds of $492,500. The shares have a four-month-and-one-day hold period expiring on March 21, 2016.

In connection with the offering, the company paid finders' fees of 10 per cent cash and 10 per cent finders' warrants for a total of $43,250 and issued 432,500 non-transferable share purchase warrants to Canaccord Genuity Corp. and Haywood Securities Inc. Each finders' warrant entitles the holder to purchase one common share of the company at an exercise price of 10 cents for a two-year period, expiring on Nov. 20, 2017.

The proceeds of the private placement will be used for expansion of its facilities in Washington State, United States, and general working capital purposes.

We seek Safe Harbor.